Table 2 Univariate and multivariate analyses of ESC-RCC and ccRCC in the training cohort.
Variables | Univariable OR (95% CI) | P value | Multivariable OR (95% CI) | P value | B | Score (points) |
|---|---|---|---|---|---|---|
Sex | 0.831 (0.257–2.685) | 0.757 | - | - | - | - |
Age | 1.011 (0.964–1.061) | 0.640 | - | - | - | - |
Maximum diameter | 0.948 (0.740–1.213) | 0.670 | - | - | - | - |
Location | 1.513 (0.469–4.881) | 0.489 | - | - | - | - |
Growth pattern of the tumour | 0.984 (0.397–2.437) | 0.972 | - | - | - | - |
Morphology and Boundaries | 2.466 (0.698–8.707) | 0.161 | - | - | - | - |
Unenhanced CT density | 0.181 (0.063–0.525) | 0.002 * | 0.194 (0.018–2.091) | 0.176 | −1.640 | - |
Intra-tumour necrosis | 30.667 (3.617−259.986) | 0.002 * | 72.587 (4.032−1306.820) | 0.004* | 4.285 | 3 |
Pseudocapsule | 9.389 (2.427–36.323) | 0.001 * | 13.734 (1.347−140.004) | 0.027* | 2.620 | 2 |
Cystic changes | 1.098 (0.524−2.300) | 0.805 | - | - | - | - |
Calcification | 0.383 (0.003–5.052)† | 0.505† | - | - | - | - |
Haemorrhage | 0.200 (0.001–2.050)† | 0.203† | - | - | - | - |
Degree of CMP enhancement | 16.364 (3.178–84.268) | <0.001 * | 29.130 (2.541−333.882) | 0.007 * | 3.372 | 3 |
Enhancement pattern | 8.571 (2.217–33.147) | 0.002 * | 8.235 (0.714–95.002) | 0.091 | 2.108 | - |
